Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2014, Article ID 826453, 2 pages
Case Report

Octreotide for the Management of Gastrointestinal Bleeding in a Patient with a HeartWare Left Ventricular Assist Device

1Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
2Advanced Heart Failure and Transplant Cardiology, Medical College of Wisconsin, Milwaukee, WI 53226, USA

Received 13 October 2014; Accepted 1 December 2014; Published 18 December 2014

Academic Editor: Man-Hong Jim

Copyright © 2014 Geetanjali Dang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


HeartWare is a third generation left ventricular assist device (LVAD), widely used for the management of advanced heart failure patients. These devices are frequently associated with a significant risk of gastrointestinal (GI) bleeding. The data for the management of patients with LVAD presenting with GI bleeding is limited. We describe a 56-year-old lady, recipient of a HeartWare device, who experienced recurrent GI bleeding and was successfully managed with subcutaneous (SC) formulations of octreotide.